·
We are honored to have been awarded 3rd place at the EQT Impact Challenge Hong Kong 2025, organized by the EQT Foundation that recognizes innovations creating meaningful social and environmental impact. We presented our AimGel platform and our approach to simplifying immune cell activation and expansion for cell therapy research. Our platform offers researchers a cleaner, more controllable way to work with immune cells, addressing challenges that many labs face when developing and testing immunotherapies. This recognition from global impact investors validates the work we're doing to support the cell therapy research community.
